Zacks Research Has Positive Forecast for BAX FY2026 Earnings

Key Points

• Zacks Research raised Baxter International’s FY2026 EPS forecast to $2.02 from $1.83, near the $2.04 consensus estimate, while maintaining a “Hold” rating. Its FY2027 forecast is $2.00 per share.
• Baxter’s latest quarterly results exceeded expectations, with EPS of $0.56 versus the $0.37 consensus and revenue of $2.96 billion, up 5.3% year over year. The company’s FY2026 guidance remains $1.95–$2.15 EPS.
• Analyst sentiment remains broadly neutral: the stock has a consensus “Hold” rating and a $22.45 price target, despite several firms recently raising their targets. Shares opened at $26.37, while institutional investors own 90.19% of the company.

Baxter International Inc. (NYSE:BAX - Free Report) - Equities researchers at Zacks Research upped their FY2026 earnings per share estimates for shares of Baxter International in a research report issued on Thursday, August 20th. Zacks Research analyst Team now forecasts that the medical instruments supplier will earn $2.02 per share for the year, up from their prior estimate of $1.83. Zacks Research currently has a "Hold" rating on the stock. The consensus estimate for Baxter International's current full-year earnings is $2.04 per share. Zacks Research also issued estimates for Baxter International's FY2027 earnings at $2.00 EPS.

Baxter International (NYSE:BAX - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.19. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The firm had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. During the same period in the previous year, the firm earned $0.59 EPS. Baxter International's revenue was up 5.3% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS.

Other equities analysts have also issued reports about the stock. The Goldman Sachs Group upped their price objective on shares of Baxter International from $19.00 to $21.00 and gave the stock a "neutral" rating in a report on Wednesday, July 15th. Barclays lifted their target price on shares of Baxter International from $25.00 to $27.00 and gave the company an "overweight" rating in a report on Friday, May 1st. Wells Fargo & Company boosted their target price on Baxter International from $19.00 to $23.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Citigroup upgraded Baxter International from a "sell" rating to a "neutral" rating and upped their price target for the stock from $17.00 to $28.00 in a research note on Friday, July 31st. Finally, UBS Group raised their price target on Baxter International from $19.00 to $25.00 and gave the stock a "hold" rating in a research report on Tuesday, July 28th. Two investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $22.45.

Baxter International Trading Up 0.1%

Shares of BAX stock opened at $26.37 on Monday. Baxter International has a 1-year low of $15.73 and a 1-year high of $30.00. The firm has a market cap of $13.63 billion, a PE ratio of -12.74, a price-to-earnings-growth ratio of 3.99 and a beta of 0.59. The company has a 50-day moving average of $23.62 and a two-hundred day moving average of $20.36. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.95 and a quick ratio of 1.32.

Baxter International Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, August 28th will be given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, August 28th. Baxter International's dividend payout ratio is currently -1.93%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Basepoint Wealth LLC purchased a new stake in Baxter International during the 4th quarter worth approximately $26,000. Jones Financial Companies Lllp acquired a new stake in Baxter International during the 2nd quarter worth approximately $26,000. Imprint Wealth LLC purchased a new position in Baxter International in the 3rd quarter valued at approximately $27,000. MUFG Securities EMEA plc purchased a new position in Baxter International in the 2nd quarter valued at approximately $46,000. Finally, Los Angeles Capital Management LLC acquired a new position in shares of Baxter International in the fourth quarter worth $46,000. Hedge funds and other institutional investors own 90.19% of the company's stock.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company's primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter's offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source